Time trade-off and attitudes toward euthanasia: Implications of using 'death' as an anchor in health state valuation

Quality of Life Research

Volumn 22, Issue 4, 2013, Pages 705-714

  Augestad, Liv A ^a,b   Rand Hendriksen, Kim ^b   Stavem, Knut ^a   Kristiansen, Ivar Sonbo ^a,b  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Anchor; Euthanasia; Framing effects; Health state valuation; Lead time time trade off; Time trade off

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATTITUDE TO DEATH; EUTHANASIA; FEMALE; HEALTH STATUS; HUMAN; MALE; METHODOLOGY; NORWAY; PAIN ASSESSMENT; PSYCHOMETRY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; REGRESSION ANALYSIS; SOCIAL PSYCHOLOGY; STATISTICAL MODEL; TIME; VERY ELDERLY; VISUAL ANALOG SCALE; YOUNG ADULT; PAIN MEASUREMENT; PROCEDURES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO DEATH; EUTHANASIA; FEMALE; HEALTH STATUS; HUMANS; LINEAR MODELS; MALE; NORWAY; PAIN MEASUREMENT; PSYCHOMETRICS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; REGRESSION ANALYSIS; SOCIAL VALUES; TIME FACTORS; VISUAL ANALOG SCALE; YOUNG ADULT;

EID: 84892816612     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-012-0192-9     Document Type: Article

References (46)

1. Drummond, M. F. (1997). Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press.
2. Stein, K., Fry, A., Round, A., Milne, R., & Brazier, J. (2005). What value health?: A review of health state values used in early technology assessments for NICE. Applied Health Economics and Health Policy, 4(4), 219-228.
3. Räsänen, P., Roine, E., Sintonen, H., et al. (2006). Use of Quality-Adjusted Life Years for the Estimation of Effectiveness of Health Care: A Systematic Literature Review. International Journal of Technology Assessment in Health Care, 22(02), 235-241. Available at: [Accessed September 6, 2010].
4. Williams, A. (1990). EuroQol-a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199-208.
5. Szende, A., Oppe, M., Devlin, N. J., & Group E. (2006). EQ-5D value sets: Inventory, comparative review, and user guide. Berlin: Springer.
6. Brazier, J., Ratcliffe, J., Tsuchiya, A., Joshua, S., & Brazier, J. (2007). Measuring and valuing health benefits for economic evaluation. Oxford: Oxford University Press.
7. Krabbe, P. F., Essink-Bot, M. L., & Bonsel, G. J. (1997). The comparability and reliability of five health-state valuation methods. Social Science and Medicine, 45(11), 1641-1652.
8. Szende, A., Oppe, M., & de Charro, F. (2007). Comparative review of time trade-off value sets. In A. Szende, M. Oppe, & N. Devlin (Eds.), EQ-5D Value Sets: inventory, comparative review, and user guide (pp. 21-28). Berlin: Springer.
9. Augustovski, F. A., Irazola, V. E., Velazquez, A. P., Gibbons, L., & Craig, B. M. (2009). Argentine valuation of the EQ-5D Health States. Value in Health, 12(4), 587-596.
10. Torrance, G. W., Thomas, W. H., & Sackett, D. L. (1972). A utility maximization model for evaluation of health care programs. Health Services Research, 7(2), 118.
11. Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095-1108.
12. Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Medical Care, 43(3), 203-220.
13. Chevalier, J., & Pouvourville, G. (2011). Valuing EQ-5D using Time Trade-Off in France. The European Journal of Health Economics. Accessed online, 21 September 2011.
14. Wittrup-Jensen, K. U., Lauridsen, J., Gudex, C., & Pedersen, K. M. (2009). Generation of a Danish TTO value set for EQ-5D health states. Scandinavian Journal of Public Health, 37(5), 459-466.
15. Golicki, D., Jakubczyk, M., Niewada, M., Wrona, W., & Busschbach, J. J. (2010). Valuation of EQ-5D health states in Poland: First TTO-based social value set in central and Eastern Europe. Value in Health, 13(2), 289-297.
16. Dolan, P., & Roberts, J. (2002). To what extent can we explain time trade-off values from other information about respondents? Social Science and Medicine, 54(6), 919-929.
17. Dolan, P., & Jones-Lee, M. (1997). The time trade-off: a note on the effect of lifetime reallocation of consumption and discounting. Journal of Health Economics, 16(6), 731-739.
18. Attema, A. E., & Brouwer, W. B. F. (2010). The value of correcting values: influence and importance of correcting TTO scores for time preference. Value in Health, 13(8), 879-884.
19. Salomon, J. A., & Murray, C. J. L. (2004). A multi-method approach to measuring health-state valuations. Health Economics, 13(3), 281-290.
20. Stalmeier, P. F., Lamers, L. M., Busschbach, J. J., & Krabbe, P. F. (2007). On the assessment of preferences for health and duration: maximal endurable time and better than dead preferences. Medical Care, 45(9), 835.
21. Robinson, A., & Spencer, A. (2006). Exploring challenges to TTO utilities: valuing states worse than dead. Health Economics, 15(4), 393-402.
22. Tilling, C., Devlin, N., Tsuchiya, A., & Buckingham, K. (2010). Protocols for time tradeoff valuations of health states worse than dead: A literature review. Medical Decision Making, 30(5), 610.
23. Stalmeier, P. F., Busschbach, J. J., Lamers, L. M., & Krabbe, P. F. (2005). The gap effect: Discontinuities of preferences around dead. Health Economics, 14(7), 679-685.
24. Lamers, L. M. (2007). The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value sets. Medical Care, 45(3), 238-244.
25. Craig, B. M., & Busschbach, J. J. V. (2011). Revisiting United States valuation of EQ-5D states. Journal of Health Economics, 30(5), 1057-1063.
26. Augestad, L. A., Rand-Hendriksen, K., Kristiansen, I. S., & Stavem, K. (2012). Impact of transformation of negative values and regression models on differences between the UK and US EQ-5D TTO value sets. Pharmacoeconomics. (in press).
27. Devlin, N. J., Tsuchiya, A., Buckingham, K., & Tilling, C. (2011). A uniform time trade off method for states better and worse than dead: feasibility study of the "lead time"approach. Health Economics, 20(3), 348-361.
28. Devlin, N. J., Hansen, P., & Selai, C. (2004). Understanding health state valuations: a qualitative analysis of respondents' comments. Quality of Life Research, 13(7), 1265-1277.
29. Dolan, P., Gudex, C., Kind, P., & Williams, A. (1996). The time trade-off method: results from a general population study. Health Economics, 5(2), 141-154.
30. Dictionary MW. (2005). Merriam-webster online. Retrieved June. 2005.
31. Schioldborg, P. (2000). Studenters holdninger til aktiv dodshjelp, assistert suicid og foreslatt lovendring. Tidsskrift for den Norske Laegeforening, 120(19), 2283-2288.
32. Peterson, R. A. (1994). A meta-analysis of Cronbach's coefficient alpha. Journal of Consumer Research., 21(2), 381-391.
33. Parkin, D., & Devlin, N. (2006). Is there a case for using visual analogue scale valuations in cost-utility analysis? Health Economics, 15(7), 653-664.
34. Byock, I. (2002). The meaning and value of death. Journal of Palliative Medicine, 5(2), 279-288.
35. Wang, X. T., et al. (1996). Framing effects: Dynamics and task domains. Organizational Behavior and Human Decision Processes, 68, 145-157.
36. Macran, S., & Kind, P. (2001). "Death" and the valuation of health-related quality of life. Medical Care, 39(3), 217-227.
37. David Parkin. (2011). What does a health state value of Zero mean?. Available at: http://aheblog.com/tag/eq-5d/. Accessed October 3, 2011.
38. Flynn, T. N. (2010). Using conjoint analysis and choice experiments to estimate QALY values: Issues to consider. Pharmaco-Economics, 28(9), 711-722.
39. Brazier, J., Rowen, D., Yang, Y., & Tsuchiya, A. (2011). Comparison of health state utility values derived using time trade-off, rank and discrete choice data anchored on the full health-dead scale. The European Journal of Health Economics. 1-13.
40. Devins, G. M. (1980). Contributions of health and demographic status to death anxiety and attitudes toward voluntary passive euthanasia. OMEGA-Journal of Death and Dying, 11(4), 293-302.
41. Suarez-Almazor, M., Belzile, M., & Bruera, E. (1997). Euthanasia and physician-assisted suicide: a comparative survey of physicians, terminally ill cancer patients, and the general population. Journal of Clinical Oncology, 15(2), 418-427.
42. Worthen, L. T., & Yeatts, D. E. (2001). Assisted suicide: Factors affecting public attitudes. OMEGA-Journal of Death and Dying, 42(2), 115-136.
43. Lancsar, E., & Louviere, J. (2006). Deleting "irrational" responses from discrete choice experiments: A case of investigating or imposing preferences? Health Economics, 15(8), 797-811.
44. Devlin, N. J., Hansen, P., Kind, P., & Williams, A. (2002). Logical inconsistencies in survey respondents' health state valuations-a methodological challenge for estimating social tariffs. Health Economics, 12(7), 529-544.
45. Rand-Hendriksen, K., Augestad, L. A., Dahl, F. A., Kristiansen, I. S., & Stavem K. (2012). A shortcut to mean-based time tradeoff tariffs for the EQ-5D? Medical Decision Making.
46. Lenert, L. A., Cher, D. J., Goldstein, M. K., Bergen, M. R., & Garber, A. (1998). The effect of search procedures on utility elicitations. Medical Decision Making, 18(1), 76.